The immunobiological effects of interleukin-2 in vivo
- PMID: 7954522
- PMCID: PMC11038771
- DOI: 10.1007/BF01525983
The immunobiological effects of interleukin-2 in vivo
References
-
- Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM, Finke JH. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res. 1993;53:1380–1387. - PubMed
-
- Atzpodien J, Körfer A, Franks CR, Poliwoda H, Kirchner H. Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies. Lancet. 1990;335:1509–1512. - PubMed
-
- Azuma M, Cayabyab M, Phillips JH, Lanier LL. Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol. 1993;150:2091–2101. - PubMed
-
- Baars JW, Hack CE, Wagstaff J, Eerenberg-Belmer AJM, Wolbink GJ, Thijs LG, Strack van Schijndel RJM, van der Vall HLJA, Pinedo HM. The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. Br J Cancer. 1992;65:96–101. - PMC - PubMed
-
- Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, von Eschenbach A, Itoh K. Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg. 1990;125:200–205. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources